Acute Agitation and Aggression Treatment Market Growth Prospects, Trends and Forecast up to 2027

April 9, 2021 0 By [email protected]
Press Release

acute agitation and aggression treatment market segmentation

Transparency Market Research (TMR) has published a new report on the acute agitation and aggression treatment market for the forecast period of 2019–2027. According to the report, the global acute agitation and aggression treatment market was valued at ~ US$ 2.9 Bn in 2018, and is projected to expand at a CAGR of ~ 5% from 2019 to 2027. Increase in the diagnosis of agitation and aggression in psychological illnesses, establishment of organizations to spread awareness, and rise in economic burden of psychological illness contribute to the growth of the global acute agitation and aggression treatment market.

Spreading Awareness about Agitation & Aggression and Rise in Economic Burden of Psychological Illness Drive Market 

Changing attitudes toward the diagnosis of agitation and aggression among mentally ill patients and rise in awareness about treatments boost the growth of the global acute agitation and aggression treatment market. The global acute agitation and aggression treatment market is expected to expand at a CAGR of ~ 5% from 2019 to 2027

Request a Sample of Acute Agitation and Aggression Treatment Market Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=72345

  • A number of trends have been observed in the global acute agitation and aggression treatment market. Increase in the incidences of dementia among the geriatric population, rise in burden of mental illness, surge in agitation in patients, and increase in prescriptions of anti-psychotics are likely to contribute to the growth of the acute agitation and aggression treatment market
  • Focus on research and development for the development of novel treatments for agitation and significant unmet clinical needs are likely to drive the global acute agitation and aggression treatment market. There is significant focus on research on the usage of combination drugs, which include a combination of anti-psychotic drugs and antidepressants.
  • In order to address the unmet needs, acute agitation and aggression treatment market players are focused on enhancing their research and development, and strengthening their pipeline, with emphasis on the early launch of products. For instance, in 2018, Otsuka Pharmaceutical Company and Lundbeck started their phase III trial for the evaluation of Brexpiprazole, for the treatment of agitation in Alzheimer’s disease patients.
  • However, the social stigma associated with mental illness and preference for non-pharmacological interventions are likely to hamper the growth of the global acute agitation and aggression treatment market.

Request for a Discount on Acute Agitation and Aggression Treatment Market Report -.

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=72345

Second-generation Anti-psychotics to Capture Major Market Share 

  • The acute agitation and aggression treatment market has been segmented based on drug class, route of administration, indication, end user, and region. In terms of drug class, the global acute agitation and aggression treatment market has been categorized into first-generation anti-psychotics, second-generation anti-psychotics, benzodiazepines, and others.
  • Based on indication, the global acute agitation and aggression treatment market has been classified into schizophrenia, dementia, bipolar disorder, depression, drug-induced agitation & aggression, alcohol withdrawal, and others. In terms of end user, the acute agitation and aggression treatment market has been divided into hospitals and ambulatory surgical centers, psychiatric care facilities, and others.
  • In terms of region, the global acute agitation and aggression treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

    About Us

    Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

    Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

    TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

    Contact
    Transparency Market Research
    State Tower,
    90 State Street,
    Suite 700,
    Albany NY – 12207
    United States
    Tel: +1-518-618-1030
    USA – Canada Toll Free: 866-552-3453
    Email: [email protected] 
    Website:
     http://www.transparencymarketresearch.com